Lykos Therapeutics Appoints Allison Rosenthal as Chief Commercial Officer and Coy Stout as Vice President of Market Access
Position
Vice President
Company
Lykos Therapeutics
San JoseBiotechnologyHealthcareHealth CareTherapeuticsDescription
Allison Rosenthal has been appointed as Chief Commercial Officer (CCO) and member of the Company's executive committee. Coy Stout has also joined as Vice President (VP) of Market Access. These appointments mark critical milestones as the company builds out its commercial organization and prepares for potential product launches.
Quick answer
Lykos Therapeutics Appoints Allison Rosenthal as Chief Commercial Officer and Coy Stout as Vice President of Market Access (May 3, 2024). Lykos Therapeutics is based in San Jose, California, United States.
- Who is the new Vice President at Lykos Therapeutics?
- Lykos Therapeutics named Coy Stout Vice President, announced May 3, 2024.
- What did Lykos Therapeutics announce on May 3, 2024?
- Allison Rosenthal has been appointed as Chief Commercial Officer (CCO) and member of the Company's executive committee. Coy Stout has also joined as Vice President (VP) of Market Access.
- What does Lykos Therapeutics do?
- Lykos Therapeutics is a company dedicated to transforming mental healthcare.
- Where is Lykos Therapeutics based?
- Lykos Therapeutics is based in San Jose, California, United States.
- Which similar companies made leadership changes around the same time?
- Wave Life Sciences (May 9, 2024), EyePoint, Inc. (May 9, 2024), Geneoscopy (May 15, 2024) and Recursion Pharmaceuticals (April 19, 2024) also announced leadership changes within 45 days of Lykos Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Wave Life Sciences Ltd. Appoints Erik Ingelsson, MD, PhD, as Chief Scientific Officer (May 9, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- Geneoscopy Appoints Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations (May 15, 2024)
- Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024)
- Verastem Oncology Appoints John Hayslip, M.D. as Chief Medical Officer (April 18, 2024)
- CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer (May 24, 2024)
Who to call at Lykos Therapeutics, and when
A new leader at Lykos Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lykos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lykos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lykos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lykos Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lykos Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.